Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Pharynx”

525 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 525 results

Testing effectiveness (Phase 2)Study completedNCT01262560
What this trial is testing

Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

Who this might be right for
DysphagiaLung CancerPain+1 more
Radiation Therapy Oncology Group 163
Early research (Phase 1)UnknownNCT05299203
What this trial is testing

BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 18
Not applicableUnknownNCT00577057
What this trial is testing

Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Neoplasms
Hospital Authority, Hong Kong 798
Large-scale testing (Phase 3)Ended earlyNCT00198328
What this trial is testing

Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head Neck Cancer
Inovio Pharmaceuticals 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT04609280
What this trial is testing

Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)

Who this might be right for
Head and Neck CancerOropharynx CancerOropharyngeal Squamous Cell Carcinoma
University of Maryland, Baltimore 52
Not applicableUnknownNCT06024980
What this trial is testing

Using the Subglottic Pressure to Predict the Dysphagia After Partial Laryngectomy

Who this might be right for
Laryngeal CancerDysphagia
Guangdong Provincial People's Hospital 50
Testing effectiveness (Phase 2)UnknownNCT04143984
What this trial is testing

Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center 146
Early research (Phase 1)Not Yet RecruitingNCT07741643
What this trial is testing

Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma

Who this might be right for
HNSCC,Larynx, Pharynx and Oral CavitySquamous Cell CarcinomaHead and Neck Cancer+1 more
Vanderbilt-Ingram Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT05799144
What this trial is testing

PBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

Who this might be right for
Metastatic Oropharyngeal CarcinomaRecurrent Oropharyngeal Carcinoma
Michael K. Gibson 54
Large-scale testing (Phase 3)Ended earlyNCT00537199
What this trial is testing

OraTest in Combination With Visual Examination and Visual Examination Alone

Who this might be right for
Head And Neck CancerOropharynx Cancer
M.D. Anderson Cancer Center 1
Not applicableUnknownNCT03755921
What this trial is testing

Brief and Intensive Therapy for Dysphagia in Patients With Head and Neck Cancer

Who this might be right for
Deglutition DisordersDysphagiaHead and Neck Cancer+1 more
Federal University of Health Science of Porto Alegre 20
Testing effectiveness (Phase 2)Study completedNCT04350190
What this trial is testing

Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Wei Jiang 25
Testing effectiveness (Phase 2)Study completedNCT00305734
What this trial is testing

Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Recurrent Nasopharyngeal CancerStage IV Nasopharyngeal Cancer
National Cancer Institute (NCI) 50
Not applicableEnded earlyNCT00011492
What this trial is testing

Patient Evaluation for Head and Neck Surgery Branch Studies

Who this might be right for
Head and Neck NeoplasmsPharyngeal CancerOral Cancer+2 more
National Institute on Deafness and Other Communication Disorders (NIDCD) 62
Not applicableStudy completedNCT05834712
What this trial is testing

Patients With Stage III-IVa Nasopharyngeal Carcinoma With or Without a Mobile Medical Platform Full-course Nutritional Intervention

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 224
Testing effectiveness (Phase 2)Study completedNCT00524017
What this trial is testing

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Who this might be right for
Head and Neck CancerPrecancerous Condition
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)Looking for participantsNCT06997068
What this trial is testing

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Who this might be right for
Metastatic Oral Cavity CarcinomaRecurrent Oral Cavity CarcinomaStage IVC Lip and Oral Cavity Cancer AJCC v8+15 more
Mayo Clinic 25
Large-scale testing (Phase 3)Study completedNCT01528618
What this trial is testing

Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 362
Testing effectiveness (Phase 2)Ended earlyNCT01216020
What this trial is testing

Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsLaryngeal NeoplasmsMouth Neoplasms+1 more
Azienda USL 4 Prato 70
Early research (Phase 1)Active Not RecruitingNCT04576091
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma+29 more
National Cancer Institute (NCI)
Next Page
7